HealthEquity (NASDAQ:HQY – Free Report) had its price objective trimmed by The Goldman Sachs Group from $107.00 to $94.00 in a report published on Thursday morning,Benzinga reports. The firm currently ...

NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of HealthEquity, ...

HQY stock wiped out its Trump election rally as the health savings account leader's earnings missed on elevated fraud costs.

NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of ...

Buying $1000 In HQY: If an investor had bought $1000 of HQY stock 10 years ago, it would be worth $3,618.59 today based on a ...

Fintel reports that on March 25, 2025, Raymond James upgraded their outlook for HealthEquity (NasdaqGS:HQY) from Outperform ...

HealthEquity's Q4 revenue beat estimates, but EPS missed. Raymond James upgraded the stock to Strong Buy, citing long-term growth despite fraud concerns.

HealthEquity (NASDAQ:HQY – Get Free Report) was upgraded by analysts at Raymond James from an “outperform” rating to a “strong-buy” rating in a note issued to investors on Tuesday, MarketBeat.com ...

HealthEquity stock drops after mixed Q4 results despite 18.8% revenue growth. Click here to find out why HQY stock is a Hold.

HealthEquity (HQY) came out with quarterly earnings of $0.69 per share, missing the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.63 per share a year ago.